» Articles » PMID: 30034666

Focused Parathyroidectomy for Single Parathyroid Adenoma: a Clinical Account of 20 Patients

Overview
Specialty General Medicine
Date 2018 Jul 24
PMID 30034666
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Single parathyroid adenoma is the commonest cause of primary hyperparathyroidism. Localization of the affected gland preoperatively is a critical step in management. Surgery is considered as the main line of treatment for single parathyroid adenoma. Focused technique for parathyroid excision was found by many researchers to have a good success rate even without intraoperative parathyroid hormone measurement.

Objective: The aim of this study was to assess the feasibility, safety, and adequacy of focused parathyroidectomy via an open lateral approach using preoperative positive Sestamibi (MIBI) scan and/or ultrasound without utilizing any intraoperative aiding tools.

Methods: A case-series prospective analysis of focused open parathyroidectomy for 20 patients presented to the department of surgery or referred from the orthopedic department between October 2012 and January 2015 at the Faculty of Medicine, Al-Azhar University, Cairo, Egypt, diagnosed as sporadic hyperparathyroidism with either positive MIBI scan or ultrasound were done. Normalization of the postoperative levels of serum calcium and PTH was considered as a marker of success. Data entry and analysis were done using the IBM-SPSS version 22.

Results: In this study, focused minimal access parathyroidectomy was successful in 95% with no major surgical complications, i.e., recurrent laryngeal nerve palsy or permanent hypoparathyroidism. The patient's mean age was 46.5±12 years. The preoperative serum calcium level ranged from 8.8 to 15.2 mg/dL. The parathyroid hormone level was elevated ranging from 123-2000 pg/mL. In 90% of the cases, serum levels of alkaline phosphatase were elevated, while serum phosphorus was low with range 1.5-4.7 mg/dL. The left inferior parathyroid gland was the most commonly involved gland (40%). Using ultrasound and Sestamibi scan for preoperative localization was accurate in 75% and 90%, respectively. When both techniques were combined localization accuracy increased to 95%.

Conclusion: Our study has shown that focused parathyroidectomy is considered as a good option for single gland disease even if there are no available intraoperative helping aids, provided that good patient selection is undertaken.

Citing Articles

Impact of perioperative diagnostic tools on clinical outcomes and cost-effectiveness in parathyroid surgery: a decision model-based analysis.

Batora D, Iskandar R, Gertsch J, Kaderli R BMJ Open. 2024; 14(9):e082901.

PMID: 39242156 PMC: 11381705. DOI: 10.1136/bmjopen-2023-082901.


Feasibility of focused parathyroidectomy in developing countries-a scoping review.

Rugnath K, Kinoo S Gland Surg. 2024; 13(6):1054-1065.

PMID: 39015710 PMC: 11247565. DOI: 10.21037/gs-24-57.


Questionable value of [Tc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound.

Lenschow C, Wennmann A, Hendricks A, Germer C, Fassnacht M, Buck A Langenbecks Arch Surg. 2022; 407(8):3661-3669.

PMID: 35945299 PMC: 9722861. DOI: 10.1007/s00423-022-02648-9.


Frequency of Preoperative Localization Techniques of Parathyroid Adenoma at King Abdulaziz University Hospital, Saudi Arabia.

Marzouki H, Abdulhaleem M, Qasim L, Aldajani A, Samargandy S, Alhozali A Cureus. 2021; 13(2):e13550.

PMID: 33791173 PMC: 8001217. DOI: 10.7759/cureus.13550.


Radiofrequency Ablation of Parathyroid Adenomas: Safety and Efficacy in a Study of 10 Patients.

Khandelwal A, Batra S, Jajodia S, Gupta S, Khandelwal R, Kapoor A Indian J Endocrinol Metab. 2021; 24(6):543-550.

PMID: 33643872 PMC: 7906106. DOI: 10.4103/ijem.IJEM_671_20.


References
1.
Wong W, Foo F, Lau M, Sarin A, Kiruparan P . Simplified minimally invasive parathyroidectomy: a series of 100 cases and review of the literature. Ann R Coll Surg Engl. 2011; 93(4):290-3. PMC: 3363078. DOI: 10.1308/003588411X571836. View

2.
Badii B, Staderini F, Foppa C, Tofani L, Skalamera I, Fiorenza G . Cost-benefit analysis of the intraoperative parathyroid hormone assay in primary hyperparathyroidism. Head Neck. 2016; 39(2):241-246. DOI: 10.1002/hed.24567. View

3.
Usta A, Alhan E, Cinel A, Turkyilmaz S, Erem C . A 20-year study on 190 patients with primary hyperparathyroidism in a developing country: Turkey experience. Int Surg. 2015; 100(4):648-55. PMC: 4400933. DOI: 10.9738/INTSURG-D-14-00094.1. View

4.
Calo P, Pisano G, Loi G, Medas F, Barca L, Atzeni M . Intraoperative parathyroid hormone assay during focused parathyroidectomy: the importance of 20 minutes measurement. BMC Surg. 2013; 13:36. PMC: 3848580. DOI: 10.1186/1471-2482-13-36. View

5.
Calo P, Medas F, Loi G, Erdas E, Pisano G, Nicolosi A . Feasibility of unilateral parathyroidectomy in patients with primary hyperparathyroidism and negative or discordant localization studies. Updates Surg. 2016; 68(2):155-61. DOI: 10.1007/s13304-015-0342-z. View